Radical behaviorism

University of Phoenix College of Doctoral Studies Releases Latest Edition of Its Phoenix ScholarTM Academic Journal Highlighting Research Based on Career Optimism Index® Study of the University’s Career Institute®

Retrieved on: 
Friday, August 12, 2022
Education, Other Education, Continuing, University, Woman, Scholar, Industry, Faculty, Happiness, Workplace, Leadership, Learning, Leadership studies, Radical behaviorism, Research, Workforce, Doctor, Institute, COVID-19, Center, Education, Educational technology, University of Phoenix, University, Solution, Student, Career, Management, College, Phoenix

University of Phoenix has released the 14th edition of the Phoenix Scholar academic research journal.

Key Points: 
  • University of Phoenix has released the 14th edition of the Phoenix Scholar academic research journal.
  • The issue establishes an annual edition dedicated to research generated from findings of the Career Optimism Index study produced by the University of Phoenix Career Institute , a research center of the College focused on studying American workforce dynamics.
  • The Phoenix Scholar journal is the academic research publication of University Phoenixs College of Doctoral Studies and serves as the scholarly platform for communicating the results and outcomes of university research endeavors, and their relationship to the broader scope of learning and scholarship.
  • In addition to the Career Institute and Career Optimism Index study, College research centers contributed to the publication findings, including the Center for Leadership Studies and Organizational Research (CLSOR), the Center for Educational and Instructional Technology Research (CEITR), and the Center for Workplace Diversity and Inclusion Research (CWDIR).

Spot by NetApp Announces Continuous Security Solution for Cloud Infrastructure

Retrieved on: 
Tuesday, July 26, 2022
Internet, Security, Data Management, Technology, Software, Name, NetApp, Radical behaviorism, Spot, View, Twitter, Instagram, Solution, Compliance, Fatigue, Software, DevOps, Secop, NASDAQ, Organization, Technology, LinkedIn, Anomaly, Efficiency, Security, NTAP, Risk management, Facebook

NetApp (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced the general availability of Spot Security.

Key Points: 
  • NetApp (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced the general availability of Spot Security.
  • Built for the cloud, Spot Security delivers a solution for continuous assessment and analysis of cloud security posture.
  • Spot Security enables DevOps and SecOps teams to easily collaborate to identify misconfigurations, reduce their potential attack surface, and ensure compliance.
  • Spot Security provides DevOps and SecOps a solution that meets the critical requirement to ensure the security of their dynamic cloud environment, further innovating the Spot by NetApp CloudOps suite of solutions that automate and optimize operations in the cloud.

Salt Security Platform Enhancements Make it Easier to Operationalize API Security

Retrieved on: 
Wednesday, July 20, 2022
Algorithm, Time, Salt, Radical behaviorism, Solution, Attack, Risk, Organization, Machine learning, Ecosystem, Black hat, PALO, API, Beekeeping, Synthetic oil, Risk management

PALO ALTO, Calif., July 20, 2022 /PRNewswire/ -- Salt Security, the leading API security company, today announced new enhancements to its next-generation Salt Security API Protection Platform, extending abilities in threat detection and pre-production API testing. The latest features include deeper and earlier insights into attacker behaviors and attack patterns, visual depictions of API call sequences, and support for attack simulation ahead of releasing APIs into production. With the new capabilities, Salt enhances its market-leading capabilities in runtime protection, providing organizations a more comprehensive view of API usage and the API attack surface so they can improve their business understanding and accelerate incident response time.

Key Points: 
  • PALO ALTO, Calif., July 20, 2022 /PRNewswire/ -- Salt Security , the leading API security company, today announced new enhancements to its next-generation Salt Security API Protection Platform , extending abilities in threat detection and pre-production API testing.
  • New features in the Salt Security API Protection Platform include:
    Threat hunting capabilities within more detailed attacker timelines Salt continues to be the only API security company that creates a consolidated attacker timeline.
  • Visualization of API Call Sequences Salt becomes the first API security vendor to offer a visual depiction of the various paths that API calls are following.
  • Deployed in minutes, the Salt Security platform learns the granular behavior of a company's APIs and requires no configuration or customization to pinpoint and block API attackers.

Saks Appoints Dr. Alicia Williams as Vice President of Diversity, Equity and Inclusion

Retrieved on: 
Monday, July 18, 2022
Data Management, Online Retail, Technology, Luxury, Professional Services, Department Stores, Fashion, Retail, Software, Internet, Human Resources, People, Culture, Leadership, University, Cornell University, Facebook, Saks Fifth Avenue, Towson University, TikTok, Morgan Stanley, Equity, Twitter, DEI, Harvard University, Radical behaviorism, Beauty, JP, Associate, Howard University, Growth, JPMorgan Chase, SVP, Partnership, ESG, VP, Editorial, Erg, Management, Public relations, New York University, Diversity, Instagram, Inclusion

Saks, the premier luxury ecommerce platform, has appointed Dr. Alicia Williams as Vice President, Diversity, Equity and Inclusion (DEI), effective today.

Key Points: 
  • Saks, the premier luxury ecommerce platform, has appointed Dr. Alicia Williams as Vice President, Diversity, Equity and Inclusion (DEI), effective today.
  • Dr. Williams joins Saks with more than 15 years of experience as a global talent and diversity leader at Morgan Stanley, JPMorgan and top-tier academic institutions.
  • As VP, DEI, she will be responsible for furthering Saks progress on its DEI commitments across the company while shaping its go-forward strategy.
  • Dr. Williams will work closely with Saks' DEI Council, Inclusion Advocates and ERGs.

University of Phoenix College of Doctoral Studies’ Research Centers Provide Comprehensive Research Services to Business Community

Retrieved on: 
Thursday, July 7, 2022
Professional Services, Education, DEI (Diversity, Equity and Inclusion), Human Resources, Other Education, Continuing, University, University of Phoenix, Institute, Leadership studies, Economic and Business Research Center, Jobs, Career, CEO, Research, College, Student, Workforce, Program, Center, Commerce, Education, Industry, Ecosystem, Educational technology, Organizational culture, Penn State College of Education, Faculty, MBA, Perception, Technology, Communication, University, Organization, School of education, Workplace, Radical behaviorism, Doctor, Solution, Blackstone Career Institute, Underwood, Careers New Zealand, LPC, Leadership, JFF, Irving Independent School District, Management, Medicine

Our Research Center model provides a framework that understands the business community and is well-positioned to inform and advance organizational research, understanding, and workforce opportunities.

Key Points: 
  • Our Research Center model provides a framework that understands the business community and is well-positioned to inform and advance organizational research, understanding, and workforce opportunities.
  • The Research Centers are led by professional researchers and industry experts with long-standing careers in both academia and industries.
  • The mission of our Research Centers is to lead, integrate, and deliver multidisciplinary, rigorous research and development solutions in the core areas of leadership, workplace inclusion and diversity, and technology, states Hinrich Eylers, Ph.D., P.E., vice provost, College of Doctoral Studies at University of Phoenix.
  • University of Phoenixs College of Doctoral Studies focuses on todays challenging business and organizational needs, from addressing critical social issues to developing solutions to accelerate community building and industry growth.

uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

Retrieved on: 
Thursday, June 23, 2022
CNS, Dementia, Putamen, Investor, COVID-19, Chorea, Risk, Safety, CSF, Annual report, Technology, Female, CAG, Total functional programming, Huntington's disease, Brain, Thrombosis, Forward-looking statement, Research, AFL, Disease, Anticoagulant, Clinical trial, Central nervous system, Nerve, Autosome, GLOBE, NASDAQ, Phase, Compte rendu, Catheter, Patient, Haemophilia, Elbow, ID, Radical behaviorism, Conference, Male, VG, Neurodegeneration, Fabry disease, Pharmaceutical industry, Medical imaging, Health insurance

We are encouraged by this 12-month update on the patients enrolled in the low-dose cohort, stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure.

Key Points: 
  • We are encouraged by this 12-month update on the patients enrolled in the low-dose cohort, stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure.
  • Thus far in the clinical trial, AMT-130 has been well-tolerated, with no serious adverse events related to the gene therapy and NfL levels approaching baseline.
  • We look forward to presenting additional clinical data, including functional outcomes, on all patients from this important study next year.
  • We look forward to continued collaboration with the Huntingtons disease community to advance AMT-130 as a potential treatment for those living with Huntingtons disease.

University of Phoenix College of Doctoral Studies Releases New Edition of Its Phoenix Scholar™ Academic Journal

Retrieved on: 
Wednesday, June 22, 2022
Education, Research, Continuing, Science, Training, University, Solution, Time, Education, Industry, Learning, Workplace, Faculty, Leadership studies, Commerce, VUCA, Doctor, Leadership, Student, Careers New Zealand, Research, Educational technology, University of Phoenix, Interview, Ecosystem, University, Program, Radical behaviorism, Center, Organization, Management, Phoenix

University of Phoenix has released the 13th edition of the Phoenix Scholar academic research journal.

Key Points: 
  • University of Phoenix has released the 13th edition of the Phoenix Scholar academic research journal.
  • The Phoenix Scholar journal is the academic research publication of University Phoenixs College of Doctoral Studies and serves as the scholarly platform for communicating the results and outcomes of university research endeavors, and their relationship to the broader scope of learning and scholarship.
  • University of Phoenixs College of Doctoral Studies focuses on todays challenging business and organizational needs, from addressing critical social issues to developing solutions to accelerate community building and industry growth.
  • University of Phoenix is continually innovating to help working adults enhance their careers in a rapidly changing world.

Study Explains Molecular Basis of Long COVID Symptoms

Retrieved on: 
Tuesday, June 7, 2022
NYU Langone Health, Human, Macrophage, Infection, Biology, COVID, Cognition, Research, Cell, Brain, Anxiety, Lung, Influenza A virus, Behavior, Doctor of Philosophy, Pathology, Depression, Olfactory bulb, RNA, Degenerative disease, New York University Grossman School of Medicine, Inflammation, Mortimer, Weill Cornell Medicine, Smell, National Institutes of Health, Harvard University, Biophysics, Science Translational Medicine, Cell biology, Patient, Influenza, Systems biology, Medical laboratory, Scar, National, COVID-19, Immune system, Mouse, Columbia University, Severe acute respiratory syndrome coronavirus 2, NYU, Cytokine, G.H. Raisoni Department of Microbiology and Biotechnology, Mark (given name), Virus, Microglia, Department, SARS-COV-2, Tissue, Bacteria, Nasal cavity, Radical behaviorism, Vaccine, Medicine, Microbiology

NEW YORK, June 7, 2022 /PRNewswire/ --A new study provides a better understanding of how the pandemic virus causes depression, anxiety, and the loss of concentration known as "brain fog" in patients that develop long COVID.

Key Points: 
  • NEW YORK, June 7, 2022 /PRNewswire/ --A new study provides a better understanding of how the pandemic virus causes depression, anxiety, and the loss of concentration known as "brain fog" in patients that develop long COVID.
  • Published online June 7in Science Translational Medicine, the study is the first to show that hamsters previously infected with SARS-CoV-2 develop a unique inflammatory response in olfactory tissue, say the study authors.
  • The findings also confirmed that the prolonged immune reactions seen in long COVID are happening in tissues where the SARS-COV-2 virus is no longer present.
  • Depression and anxiety are common attributes of long COVID, and these behavioral abnormalities were found to correlate with unique changes to the brain cell biology, the researchers say.

FORUS Therapeutics Inc ("FORUS") Announces XPOVIO® (selinexor) Is Authorized for Sale by Health Canada

Retrieved on: 
Tuesday, June 7, 2022
MM, Life, Oncology, Caregiver, Adult, Multiple myeloma, Radical behaviorism, Lymphatic system, CEO, Professor, Disease, Plasma cell, Solution, Physician, Sale, Tumor suppressor gene, Therapy, Growth, Bortezomib, Master of Science, Health Canada, Myeloma Canada, Patient, Program, B cell, XPO1, Immune system, Antibody, SINE, Dexamethasone, Department, Princess Margaret Cancer Centre, Bone marrow, Hematology, Cancer, Pharmaceutical industry

This is the first regulatory approval for XPOVIO in Canada in multiple myeloma and follows recent approvals in Australia, China, South Korea, Singapore and the United States.

Key Points: 
  • This is the first regulatory approval for XPOVIO in Canada in multiple myeloma and follows recent approvals in Australia, China, South Korea, Singapore and the United States.
  • "The FORUS team is very proud to launch XPOVIO in Canada and bring forth a novel and effective addition to existing regimens for the treatment of relapsed or refractory multiple myeloma.
  • XPOVIO is a registered trademark of Karyopharm Therapeutics Inc. and is used by FORUS Therapeutics Inc. under license.
  • FORUS Therapeutics is a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer.

SentinelOne Announces Integration with AWS Security Hub

Retrieved on: 
Thursday, June 2, 2022
Security, Technology, Other Technology, Software, Networks, Internet, Cloud, Sentinel, Â, Radical behaviorism, ASFF, Product management, XDR, CEO, AWS, API, Organization, Workload, Endpoint detection and response, Singularity, IOT, Anomaly, Metadata, VMS, NYSE, Application Control Management System, Amazon Web Services, Running, Forging, Medical imaging, Risk management, SentinelOne

Available via the SentinelOne Singularity Marketplace , the new integration filters high-fidelity threat information from SentinelOne agents running on Amazon Web Services (AWS) through AWS Security Hub.

Key Points: 
  • Available via the SentinelOne Singularity Marketplace , the new integration filters high-fidelity threat information from SentinelOne agents running on Amazon Web Services (AWS) through AWS Security Hub.
  • As part of our end-to-end anti-ransomware automation, we use Singularity XDR and SentinelOne for AWS Security Hub to centralize visibility and protection of endpoints as well as workloads in AWS.
  • The SentinelOne integration for AWS Security Hub delivers high-fidelity threat information from SentinelOne agents running on AWS workloads to AWS Security Hub.
  • The integration retrieves findings, including metadata, from the SentinelOne console and pushes them to AWS Security Hub, enabling incident investigation directly from AWS Security Hub.